FRESENIUS KABI PHARMA PORTUGAL,LDA secures contract for Acquisition Of Tocilizumab 162 Mg/ 0.9 Ml Sol Inj Sc Biosimilar Singringa (Tyenne)

Portugal, Aug. 8 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL,LDA has secured contract from Unidade Local De Saude De Santa Maria, E. P. E. for Acquisition Of Tocilizumab 162 Mg/ 0.9 Ml Sol Inj Sc Biosimilar Singringa (Tyenne). The value of the contract is worth 5686128 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....